(a) The efficacy of the drug;
(b) The cost of the drug;
(c) Potential side effects of the drug;
(d) A patient’s profile; and
(e) A patient’s history with the drug.
(2) The Mental Health Clinical Advisory Group consists of 18 members appointed by the authority as follows:
(a) Two psychiatrists each with an active community practice;
(b) One child and adolescent psychiatrist;
(c) Two licensed clinical psychologists;
(d) One psychiatric nurse practitioner with prescribing privileges;
(e) Two primary care providers;
(f) Two pharmacists, one of whom must have experience dispensing to long term care facilities and patients with special needs;
(g) Two individuals, each representing a statewide mental health advocacy organization for children and adults with mental illness, who have experience as a consumer of mental health services or as a family member of a consumer of mental health services;
(h) Two individuals each representing a coordinated care organization;
(i) One consumer of mental health services;
(j) One member of a federally recognized Oregon Indian tribe;
(k) One member who represents the Department of Corrections who has a clinical background; and
(L) One member who is a clinical psychiatrist and who represents the Oregon Psychiatric Access Line.
(3) The Mental Health Clinical Advisory Group shall, in developing treatment algorithms, consider all of the following:
(a) Peer-reviewed medical literature;
(b) Observational studies;
(c) Studies of health economics;
(d) Input from patients and physicians; and
(e) Any other information that the group deems appropriate.
(4) The Mental Health Clinical Advisory Group shall make recommendations to the authority and the Pharmacy and Therapeutics Committee, including but not limited to:
(a) Implementation of evidence-based algorithms.
(b) Any changes needed to any preferred drug list used by the authority.
(c) Practice guidelines for the treatment of mental health disorders with mental health drugs.
(d) Coordinating the work of the group with an entity that offers a psychiatric advice hotline.
(5) Recommendations of the Mental Health Clinical Advisory Group shall be posted to the website of the authority no later than 30 days after the group approves the recommendations.
(6) No later than December 31 of each year, the Mental Health Clinical Advisory Group shall report to the interim committees of the Legislative Assembly related to health on recommendations made to the authority under subsection (4) of this section and the report may include recommendations for legislation.
(7) A member of the Mental Health Clinical Advisory Group is not entitled to compensation but may be reimbursed for necessary travel expenses incurred in the performance of the member’s official duties.
(8) The Mental Health Clinical Advisory Group shall select one of its members as chairperson and another as vice chairperson, for terms and with duties and powers necessary for the performance of the functions of the group.
(9) A majority of the members of the Mental Health Clinical Advisory Group constitutes a quorum for the transaction of business.
(10) The Mental Health Clinical Advisory Group shall meet at least once every two months at a time and place determined by the chairperson. The group also may meet at other times and places specified by the call of the chairperson or of a majority of the members of the group. The group may meet in executive session when discussing factors listed in subsection (1) of this section.
(11) All agencies of state government, as defined in ORS 174.111, are directed to assist the Mental Health Clinical Advisory Group in the performance of duties of the group and, to the extent permitted by laws relating to confidentiality, to furnish information and advice the members of the group consider necessary to perform their duties. [2019 c.544 §1]
Note: 414.359 was enacted into law by the Legislative Assembly but was not added to or made a part of ORS chapter 414 or any series therein by legislative action. See Preface to Oregon Revised Statutes for further explanation.